Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial

Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial

Abstract Background This study was conducted to assess the efficacy and safety of the three dose levels of the three-dimensional autologous chondrocyte implantation product chondrosphere® in the treatment of cartilage defects (4–10 cm2) of knee joints. We hereby report the safety results for a 36-mo...

Full description

Bibliographic Details
Main Authors: Christoph Becher, Volker Laute, Stefan Fickert, Wolfgang Zinser, Philipp Niemeyer, Thilo John, Peter Diehl, Thomas Kolombe, Rainer Siebold, Jakob Fay
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Knee
ACI
Cartilage
Safety
Prospective randomised trial
Online Access:http://link.springer.com/article/10.1186/s13018-017-0570-7

Similar Items

Similar Items